RxDoctor Payments Data

Angela Caliendo

Infectious Disease · Providence, RINPI 1063470995

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,650 of the $66,139 with a category attached, or 78.1%. 4 manufacturers reported payments, led by Visby Medical, Inc. at 52.9% of the total. Among infectious disease clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,139in general payments, 2019–2025

Across 23 payments — averaging $2875.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Visby Medical, Inc.$35K
  • Quidel Corporation$19K
  • Roche Diagnostics Corporation$7K
  • Cepheid$5K
$12,270in research payments, 2019–2025

Across 24 payments — averaging $511.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$12K

What the payments were for

  • Consulting fees$51,65078%
  • Speaking & faculty fees$12,00018%
  • Travel & lodging$1,9213%
  • Food & beverage$5681%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Visby Medical, Inc.7$35,000
Quidel Corporation4$18,708
Roche Diagnostics Corporation10$7,181
Cepheid2$5,250

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,139 in reported general payments places this provider in the 95th percentile of 52 infectious disease providers in Rhode Island.

See all infectious disease providers in Rhode Island

Medicare billing

Part B allowed, 2024
$6,430
Medicare patients
25
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →